ACR TI-RADS 3、4、5 甲状腺结节在细胞学、基因印记和组织学上各具特征
研究分析 1199 个可疑甲状腺结节(TI-RADS 3 为 384 个、4 为 569 个、5 为 246 个),比较细针穿刺细胞学、分子检测与组织学结果。TI-RADS 3、4、5 结节的总体恶性率分别为 2.0%、14%、52%,高危突变在 TI-RADS 5 中更常见,提示三者在细胞学、分子和组织学上各具特征。
要点
- TI-RADS 3 结节总体恶性率 2.0%(8/384),细胞学良性占 75%。
- TI-RADS 4 结节总体恶性率 14%(77/569),切除结节中 65% 证实为癌。
- TI-RADS 5 结节总体恶性率 52%(129/246),高危突变更常见。
核心结论
- TI-RADS 3、4、5 结节在细胞学、分子和组织学上各具特征,TI-RADS 3 和 4 恶性风险较低,TI-RADS 5 恶性风险高且与更高死亡率相关。
研究设计与样本
- 研究共纳入 1199 个可疑甲状腺结节,按 TI-RADS 3(n=384)、TI-RADS 4(n=569)、TI-RADS 5(n=246)分层。
- 将细针穿刺细胞病理学和分子检测结果与电子病历中的临床数据相关联。
主要发现
- TI-RADS 3 结节中 75%(287/384)细胞学良性,仅 1 例诊断为甲状腺乳头状癌(PTC),48 个切除结节中 8 个(17%)证实为癌。
- TI-RADS 4 结节中 10%(56/569)细胞学可疑或诊断为 PTC,130 个切除结节中 85 个(65%)证实为癌。
- TI-RADS 5 结节中 44%(109/246)细胞学可疑或诊断为 PTC,154 个切除结节中 129 个(84%)为恶性。
- 高危突变在 TI-RADS 5 中比 TI-RADS 3 和 4 更常见。
- 总体恶性率:TI-RADS 3 为 2.0%(8/384),TI-RADS 4 为 14%(77/569),TI-RADS 5 为 52%(129/246)。
临床怎么用
- TI-RADS 3 和 4 结节恶性风险较低,可结合细胞学和分子结果进行风险分层管理。
- TI-RADS 5 结节恶性风险高,应积极评估并考虑手术切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid nodules, found in up to 68% of adults, can be risk-stratified by high-resolution ultrasound. This study evaluates the concordance between "suspicious" Thyroid Imaging Reporting and Data System (TI-RADS) 3-5 nodules and cytologic and molecular findings from fine-needle aspiration. METHODS: A total of 1199 suspicious thyroid nodules stratified as TI-RADS 3 (n = 384), TI-RADS 4 (n = 569), and TI-RADS 5 (n = 246) were studied. Cytopathologic and molecular results were correlated with clinical data from electronic medical records. RESULTS: Cytology, histology, and molecular testing revealed a lower risk of malignancy in TI-RADS 3 and 4 nodules compared to TI-RADS 5. Among TI-RADS 3 nodules, 75% (287 of 384) were cytologically benign, with only one case diagnosed as papillary thyroid carcinoma (PTC), and 8 of 48 resected nodules (17%) confirmed as carcinoma. In TI-RADS 4, 10% (56 of 569) were suspicious for or diagnosed as PTC by cytology, with 85 of 130 (65%) resected nodules confirmed as carcinoma. In TI-RADS 5, 44% (109 of 246) were cytologically suspicious for or diagnosed as PTC, and 129 of 154 (84%) resected nodules were malignant. High-risk mutations were more frequent in TI-RADS 5 than in TI-RADS 3 and 4. Overall malignancy rates were 2.0% (eight of 384) for TI-RADS 3, 14% (77 of 569) for TI-RADS 4, and 52% (129 of 246) for TI-RADS 5 nodules. CONCLUSION: TI-RADS 3, 4, and 5 nodules demonstrate distinct cytologic, molecular, and histologic features. TI-RADS 3 and 4 nodules are associated with lower malignancy risks, whereas TI-RADS 5 nodules exhibit a high risk of malignancy and are associated with higher mortality.
引用
- Yu S, Wang M, Langdon J, et al. American College of Radiology-Developed Thyroid Imaging Reporting and Data System 3, 4, and 5 thyroid nodules are distinctive by cytology, genetic imprints, and histology. Cancer Cytopathol. 2025. PMID: 41021263. doi:10.1002/cncy.70050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。